Henry Silver
Haifa, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: May 24, 2016
Colour influences perception of facial emotions but this effect is impaired in healthy ageing and schizophrenia.
Journal: Cognitive neuropsychiatry
Published: September 24, 2015
Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients.
Journal: International clinical psychopharmacology
Published: March 11, 2015
Social cognition in schizophrenia and healthy aging: differences and similarities.
Journal: Schizophrenia research
Published: March 21, 2014
What is "effective treatment" for a schizophrenic inpatient with persistent treatment-resistant psychosis and severe violent behavior?: a case of ECT.
Journal: The journal of ECT
Published: November 23, 2013
Add-on fluvoxamine and negative symptoms of schizophrenia: analysis of data from augmentation studies in a single center.
Journal: Journal of clinical psychopharmacology
Published: August 01, 2013
Pathways to similar executive impairment: comparison of schizophrenia patients and healthy aging individuals.
Journal: Psychiatry research
Published: December 26, 2012
The role of GABA-A receptor in the synergism between SSRI and antipsychotic in schizophrenia; implications for antipsychotic modes of actions.
Journal: Current medicinal chemistry
Published: July 15, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026